Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3003035 | 0.98 | MVD (0.39) | MVDBTN3A1 | |
| Bromohydrin Triphosphate SCHEMBL2034171 | 0.93 | MVD (0.46) | MVDBTN3A1 | |
| Bromohydrin Pyrophosphate SCHEMBL4309089 | 0.93 | MVD (0.48) | MVDBTN3A1 | |
| Bromohydrin Pyrophosphate SCHEMBL2968174 | 0.93 | MVD (0.48) | MVDBTN3A1 | |
| Bromohydrin Pyrophosphate SCHEMBL2037203 | 0.93 | MVD (0.48) | MVDBTN3A1 | |
| SCHEMBL13101843 | 0.91 | MVD (0.37) | MVDBTN3A1 | |
| SCHEMBL3003036 | 0.87 | MVD (0.40) | MVDBTN3A1 | |
| SCHEMBL21068019 | 0.85 | LPAR3 (0.39) | MVD | |
| SCHEMBL4309091 | 0.85 | LPAR3 (0.39) | MVD | |
| SCHEMBL4309087 | 0.83 | CYP3A4 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068179-A1 | Phosphohalohydrins, Process For The Production Thereof And Use Thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2010-03-18 | — | — | US | disclosed |
| US-7625879-B2 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2009-12-01 | — | — | US | disclosed |
| US-20060287281-A1 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2006-12-21 | — | — | US | disclosed |
| US-7109183-B2 | Phosphohalohydrins, process for the production thereof and use thereof | Institut National de la Sante et de la Recherchik Medicale (FR) | 2006-09-19 | — | — | US | disclosed |
| US-20040087555-A1 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICATE (FR) | 2004-05-06 | — | — | US | disclosed |
| US-6660723-B1 | Activating primate gamma delta lymphocytes | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2003-12-09 | — | — | US | disclosed |
| EP-1109817-B1 | PHOSPHOHALOHYDRINS, METHOD FOR MAKING SAME AND USES | INST NAT SANTE RECH MED (FR) | 2002-06-05 | — | — | EP | disclosed |
| EP-1109817-A1 | PHOSPHOHALOHYDRINS, METHOD FOR MAKING SAME AND USES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000012516-A1 | PHOSPHOHALOHYDRINS, METHOD FOR MAKING SAME AND USES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2000-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087555-A1 | Phosphohalohydrins, process for the production thereof and use thereof | CD4, HRH3, HRH1 | MVD 2341/4885BTN3A1 24/4885 |
| US-20060287281-A1 | Phosphohalohydrins, process for the production thereof and use thereof | CD4, CCR9, BCL9 | MVD 1563/4885BTN3A1 15/4885 |
| US-20100068179-A1 | Phosphohalohydrins, Process For The Production Thereof And Use Thereof | CD4, CCR9, ICOS | MVD 1784/4885BTN3A1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.